echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The awarding ceremony of "the second (2016) China pharmaceutical innovation brand series selection activity" was held in Jinglong

    The awarding ceremony of "the second (2016) China pharmaceutical innovation brand series selection activity" was held in Jinglong

    • Last Update: 2017-03-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on the evening of March 12, 2017, the awarding ceremony of "the second (2016) China pharmaceutical innovation brand series selection activity" jointly sponsored by Chinese Academy of Medical Sciences, Chinese Academy of traditional Chinese medicine, China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical promotion association") and people's network was held in Beijing Chen Zhu, vice chairman of the Standing Committee of the National People's Congress, chairman of the Central Committee of the agricultural labor party and academician of the Chinese Academy of Sciences, sang Guowei, vice chairman of the Standing Committee of the Eleventh National People's Congress, chief technologist of major new drug creation science and technology, academician of the Chinese Academy of engineering, Wang Guoqiang, deputy director of the national health and Family Planning Commission and director of the State Administration of traditional Chinese medicine, and member of the state health and Family Planning Commission Liu Qian, former deputy director of the conference, He Wei, member of the Standing Committee of the National Committee of the Chinese people's Political Consultative Conference and vice chairman of the Central Committee of the agricultural labor party, Wu Zhen, deputy director of the State Food and drug administration, Qin Huaijin, director of the national major new drug creation science and technology project (hereinafter referred to as the major new drug project), director of the science and Education Department of the national health and Family Planning Commission, Wu Haidong, deputy director of the consumer goods industry department of the Ministry of industry and information technology and other leaders attended the award ceremony And awards to the award-winning enterprises and individuals Chen Kaixian, academician of Chinese Academy of Sciences and deputy chief engineer of national major new drug technology, Ge Junbo, academician of Chinese Academy of Sciences and director of Cardiology Department of Zhongshan Hospital Affiliated to Shanghai Fudan University, Wang Guangji, academician of Chinese Academy of engineering and professor of China Pharmaceutical University, Chen Jianfeng, academician of Chinese Academy of engineering and Dean of School of chemical engineering of Beijing University of chemical technology, as well as famous experts and scholars active in the pharmaceutical industry Over 160 guests attended the award ceremony, including entrepreneurs, shortlisted varieties, people and representatives of enterprises Yu Qingming, the leader and guest editor in chief of the people's network, delivered a speech as the representative of the sponsor He said that to be an excellent and strong Chinese medicine brand, we should firmly grasp the key of innovation The media should objectively present the innovative achievements of Chinese medicine and realize the original intention of media communication Yu Qing, editor in chief of people's network, addressed the president of Chinese Academy of traditional Chinese medicine, President of Tianjin University of traditional Chinese medicine, deputy chief engineer of major new drug special technology, and academician Zhang Boli, vice president of China Association for the promotion of medicine as the representative of the sponsor In his speech, he pointed out that the selection activity jointly sponsored by the four units is an important embodiment of the important instruction of "promoting the transformation of Chinese products to Chinese brands" put forward by the general secretary of internship in response to the requirements of national innovation driven strategy Academician Zhang Boli delivered a speech to song Ruilin, executive chairman of China Pharmaceutical Association, and introduced the purpose, selection rules and organization of this selection activity He pointed out that the purpose of brand selection is to implement the national innovation brand strategy, promote innovation and brand building in the pharmaceutical industry, adhere to the public welfare and non-profit, do not accept the sponsorship of any enterprises and institutions, and ensure the fairness and justice of the selection activities from the source The main evaluation criteria of this selection are drug innovation, clinical and social value, and adhere to the principle of "prefer lack to abuse" Following the organizational model of the first evaluation, an independent evaluation organizing committee and an evaluation expert committee were established in this evaluation, including 46 authoritative experts in clinical medicine and pharmacy In order to enhance the authority of this selection, the organizing committee, on the basis of summarizing the experience of the first selection, carried out the expert recommendation system for the declared varieties for the first time, and optimized the award setting, evaluation process and evaluation criteria; in order to promote the innovation and modernization development of traditional Chinese medicine, except for the "most clinically alternative generic drugs", the other categories set up separate awards for traditional Chinese medicine; and We commend the experts and scholars who have played an important role in promoting the innovation of Chinese medicine and improving the policy environment of Chinese medicine innovation In addition, we specially set up the lifetime achievement award of Chinese medicine innovation Song Ruilin, executive chairman of China Association for the promotion of drugs, made a speech and was recommended by experts in the industry 42 projects were shortlisted in the four awards of "innovative drugs, innovative enterprises, innovative people and generic drugs" After comprehensive online public voting and expert evaluation results, the list of awards is as follows: 1 Academician of Chinese Academy of engineering, chief engineer of national major new drug creation technology major special technology, sang guowei-2, the most clinically valuable innovative drug 1 Chemical medicine: xidaban (epsilon) Shenzhen micro core Biotechnology Co., Ltd 2 Biological medicine: recombinant human urokinase for injection (puyouke) Shanghai Tianshili Pharmaceutical Co., Ltd 3 Chinese medicine: ginkgolide injection Chengdu Baiyu Pharmaceutical Co., Ltd 3 Generic medicine with the most clinical alternative value 1 Entecavir raw materials and dispersible tablets (Runzhong) Zhengda Tianqing Pharmaceutical Group Co., Ltd 2 Docetaxel injection (AI Su) Jiangsu Hengrui Pharmaceutical Co., Ltd 3 Pemetrexed disodium for injection (saizhen) Qilu Pharmaceutical Co., Ltd 4 The most innovative pharmaceutical enterprise 1 Manufacturer: LVYE Pharmaceutical Group, Xiansheng Pharmaceutical Co., Ltd 2 R & D enterprise: Xinda biopharmaceutical (Suzhou) Co., Ltd 3 Traditional Chinese medicine enterprise: Taiji Group Co., Ltd 5 The most influential and innovative person 1 The most influential leaders in pharmaceutical innovation enterprises: Ding Liming (Chairman and CEO of Beida Pharmaceutical Co., Ltd.), Xiao Wei (founder and chairman of Jiangsu Kangyuan Pharmaceutical Co., Ltd.) 2 The most influential leaders in pharmaceutical research and development: Su Weiguo (chief technology officer of Hutchison Huangpu Pharmaceutical (Shanghai) Co., Ltd.) 3 Cui Yimin (director of clinical trial center of Peking University First Hospital), academician sang Guowei, vice chairman Chen Zhu, former vice chairman Liu Qianyuan and chairman song Ruilin, the most influential clinical research leader of drugs, took a group photo with the winners and awarding guests of "most clinical alternative value generic drugs" "Most influential innovative person" winners and awarding guests take a group photo of "most clinically valuable innovative medicine" winners and awarding guests take a group photo of "most innovative pharmaceutical enterprise" winners and awarding guests this year's selection is highly concerned by the industry According to the statistics of people's network, during the period of opening public online voting on relevant evaluation varieties from January 15 to 25, the total number of public votes reached 97.16 million, and the actual effective number of votes was 9.17 million, about three times higher than the number of public votes in the first evaluation; nearly 300000 people praised, 50% higher than the number of people praised in the first evaluation; the number of website visits reached 220 million The varieties and enterprises awarded in this selection have received special support for major new drugs, which highlights the important contribution of major new drugs to promote drug research and development and industrial technological innovation capability, and also reflects the significance of this selection to help promote innovation transformation of the pharmaceutical industry and accelerate the construction of Chinese pharmaceutical innovation brand Group photo of leaders, awarding guests and winners As one of the organizers of this event, China pharmaceutical promotion association will continue to adhere to the purpose of "focusing on innovation and building brand" in 2017, and hold the "third (2017) China pharmaceutical innovation most influential brand selection activity", in order to promote the positive energy of pharmaceutical industry innovation, expand the radiation effect of pharmaceutical innovation brand in large and medium-sized countries, promote the continuous development of Chinese pharmaceutical innovation, and protect people Make greater contribution to people's health and well-being Award ceremony venue 1 Award Ceremony venue 2
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.